{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-036565","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2023-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.214562+00:00","generated_at":"2026-06-10T03:39:09.506333+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ocean Biomedical announces $10M convertible debt term sheet from largest stockholder; amends equity facility","bullets":["Non-binding term sheet for up to $10M convertible notes from largest stockholder Poseidon Bio at $10.34 conversion, $11.50 warrants, 1-year maturity.","Amendment to White Lion equity line allows fixed purchases at $7.00/share when stock price >=$9.00, up to 50,000 shares per notice.","No shares have been issued under the original $75M common stock purchase agreement with White Lion.","Proposed debt facility is unsecured, junior to senior lender, and requires senior lender consent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-036565","json":"https://secwatch.observer/filing/0001493152-23-036565.json","markdown":"https://secwatch.observer/filing/0001493152-23-036565.md","text":"https://secwatch.observer/filing/0001493152-23-036565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223036565/0001493152-23-036565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223036565/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:39:09.506333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12b5af37505344f99fa3c33c3d6b4ab379614fc2","claim":"Ocean Biomedical, Inc. amended First Amendment to Common Stock Purchase Agreement with White Lion Capital LLC (effective 2023-10-04).","evidence_excerpt":"Effective October 4, 2023, the Company and White Lion entered into a first amendment to the Common Stock Purchase Agreement (the “Amendment”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223036565/0001493152-23-036565-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"White Lion Capital LLC"},{"label":"Effective","value":"2023-10-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}